THE EVALUATION OF IMMUNE RESPONSES TO SARS-COV-2 MRNA VACCINES IN MULTIPLE SCLEROSIS PATIENTS ON OCRELIZUMAB
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Observational
Locations
Outpatient CTRC
University of Colorado Hospital
Study ID
Protocol Number: 21-3126
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers